CACNA1E) or Cav2.3 which in humans is encoded by the CACNA1Egene.[1][2][3]
They are strongly expressed in cortex, hippocampus, striatum, amygdala and interpeduncular nucleus.[4]
They are poorly understood, but like Q-type calcium channels, they appear to be present in cerebellar granule cells. They have a high threshold of activation and relatively slow kinetics.
McNaughton NC, Green PJ, Randall AD (December 2001). "Inhibition of human alpha1E subunit-mediated ca2+ channels by the antipsychotic agent chlorpromazine". Acta Physiologica Scandinavica. 173 (4): 401–8.
Toro-Castillo C, Thapliyal A, Gonzalez-Ochoa H, Adams BA, Meza U (January 2007). "Muscarinic modulation of Cav2.3 (R-type) calcium channels is antagonized by RGS3 and RGS3T". American Journal of Physiology. Cell Physiology. 292 (1): C573–80.
Kang HW, Moon HJ, Joo SH, Lee JH (December 2007). "Histidine residues in the IS3-IS4 loop are critical for nickel-sensitive inhibition of the Cav2.3 calcium channel". FEBS Letters. 581 (30): 5774–80.
Nyholt DR, LaForge KS, Kallela M, Alakurtti K, Anttila V, Färkkilä M, Hämaläinen E, Kaprio J, Kaunisto MA, Heath AC, Montgomery GW, Göbel H, Todt U, Ferrari MD, Launer LJ, Frants RR, Terwindt GM, de Vries B, Verschuren WM, Brand J, Freilinger T, Pfaffenrath V, Straube A, Ballinger DG, Zhan Y, Daly MJ, Cox DR, Dichgans M, van den Maagdenberg AM, Kubisch C, Martin NG, Wessman M, Peltonen L, Palotie A (November 2008). "A high-density association screen of 155 ion transport genes for involvement with common migraine". Human Molecular Genetics. 17 (21): 3318–31.
Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, Hara Y, Nishida M, Numata T, Medina MT, Takeuchi T, Morita R, Bai D, Ganesh S, Sugimoto Y, Inazawa J, Bailey JN, Ochoa A, Jara-Prado A, Rasmussen A, Ramos-Peek J, Cordova S, Rubio-Donnadieu F, Inoue Y, Osawa M, Kaneko S, Oguni H, Mori Y, Yamakawa K (August 2004). "Mutations in EFHC1 cause juvenile myoclonic epilepsy". Nature Genetics. 36 (8): 842–9.
Hainsworth AH, McNaughton NC, Pereverzev A, Schneider T, Randall AD (April 2003). "Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents". European Journal of Pharmacology. 467 (1–3): 77–80.
Kamp MA, Krieger A, Henry M, Hescheler J, Weiergräber M, Schneider T (March 2005). "Presynaptic 'Ca2.3-containing' E-type Ca channels share dual roles during neurotransmitter release". The European Journal of Neuroscience. 21 (6): 1617–25.
Meza U, Thapliyal A, Bannister RA, Adams BA (January 2007). "Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels". Molecular Pharmacology. 71 (1): 284–93.
Bernatchez G, Sauvé R, Parent L (November 2001). "State-dependent inhibition of inactivation-deficient Ca(V)1.2 and Ca(V)2.3 channels by mibefradil". The Journal of Membrane Biology. 184 (2): 143–59.
Pereverzev A, Leroy J, Krieger A, Malécot CO, Hescheler J, Pfitzer G, Klöckner U, Schneider T (October 2002). "Alternate splicing in the cytosolic II-III loop and the carboxy terminus of human E-type voltage-gated Ca(2+) channels: electrophysiological characterization of isoforms". Molecular and Cellular Neurosciences. 21 (2): 352–65.
